Related Experiment Video
Updated: Jun 18, 2026
11:01
Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
Biomaterial considerations for drug-eluting stents
Ed Parsonage1, Tim Girton, David Knapp
1Boston Scientific Corporation, Maple Grove, MN 55311, USA.
Summary
Long-term performance of implant biomaterials, like drug-eluting stents, is crucial. Rigorous evaluations, considering pharmaceutical, physical, and biological factors, ensure clinical success.
Area of Science:
- Biomaterials Science
- Medical Device Development
- Clinical Research
Background:
- Long-term clinical performance is the ultimate measure for implant biomaterials.
- This is a critical factor during the design and development of drug-eluting stents.
- Ensuring clinical success requires comprehensive evaluations.
Purpose of the Study:
- To outline the development process for drug-eluting stents.
- To detail the evaluation stages Boston Scientific employs.
- To highlight the importance of biomaterial selection for clinical endpoints.
Main Methods:
- A rigorous series of bench-top, preclinical, and clinical evaluations.
- Consideration of pharmaceutical, physical, and biological factors in biomaterial choice.
- Systematic approach to achieve desired clinical endpoints.
Main Results:
- Boston Scientific's structured approach to biomaterial evaluation.
- Integration of pharmaceutical, physical, and biological considerations.
- Methodology designed to ensure long-term clinical success.
Conclusions:
- Careful biomaterial selection and rigorous evaluation are essential for drug-eluting stent success.
- A multi-faceted approach (pharmaceutical, physical, biological) is key.
- The described process ensures desired clinical outcomes and long-term performance.
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...